Acidic sphingomyelinase interactions with lysosomal membranes and cation amphiphilic drugs: A molecular dynamics

Simone Scrima1,2, Matteo Lambrughi1, Lorenzo Favaro1

  • 1Cancer Structural Biology, Center for Autophagy, Recycling and Disease, Danish Cancer Institute, Copenhagen 2100, Denmark.

Insights

This study reveals how Acid Sphingomyelinase (ASM) binds to lysosomal membranes and how drugs (CADs) disrupt this interaction, offering insights into cancer therapy mechanisms.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Computational Biophysics

Background:

  • Lysosomes are crucial for cellular functions and disease, with Acid Sphingomyelinase (ASM) regulating membrane integrity.
  • Cation amphiphilic drugs (CADs) inhibit ASM and show anti-cancer effects, but their interaction mechanisms are unclear.

Purpose of the Study:

  • To investigate the structural interactions of glycosylated ASM with the lysosomal membrane.
  • To explore the effects of CADs (ebastine, hydroxyebastine, loratadine) on ASM and membrane dynamics.

Main Methods:

  • All-atom explicit solvent molecular dynamics simulations were employed.
  • Investigated glycosylated ASM association with the lysosomal membrane.
  • Analyzed the impact of specific CADs on ASM-membrane interactions.

Main Results:

  • Confirmed ASM membrane association via the saposin domain, elucidating residue roles and membrane curvature effects.
  • Demonstrated CADs interfere with ASM-membrane binding by interacting with a catalytic domain loop.
  • Provided a computational framework applicable to diverse CADs and membrane compositions.

Conclusions:

  • The study elucidates the molecular mechanisms of ASM-lysosomal membrane association and CAD interference.
  • Offers a valuable computational tool for future research on ASM, CADs, and lysosomal membrane dynamics.
  • Provides foundational insights for developing novel anti-cancer therapies targeting ASM.